MIRM earnings date and last-quarter result: next report 2026-07-30, last quarter miss, P/E -8.41. Updated 2026-07-23.
Mirum Pharmaceuticals (MIRM) Research Hub
Mirum Pharmaceuticals (MIRM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 83.27 USD (+3.58%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.41, market cap 5.75B. This hub links to the full technical, earnings and options research available for MIRM.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 83.27 USD (+3.58%) |
| 52-week range | 77.78 USD – 130 USD |
| Trend regime | Range |
| 14-day RSI | 56.5 (Bullish) |
| Trailing P/E | -8.41 |
| Market cap | 5.75B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for MIRM
Covered Call on MIRM: how it works, illustrative setup around the real 83.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MIRM: how it works, illustrative setup around the real 83.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MIRM: how it works, illustrative setup around the real 83.27 USD price, max profit/loss, breakeven and when to use it. Educational.
MIRM technical analysis: range, last 83.27 USD, RSI 56.5, 52w range 77.78 USD–130 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MIRM in?
Mirum Pharmaceuticals (MIRM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MIRM in an uptrend or downtrend?
As of 2026-10-26, MIRM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MIRM's trailing P/E ratio?
MIRM's trailing P/E is -8.41, with a market cap of 5.75B. See the earnings research page for full valuation detail.
When does MIRM next report earnings?
MIRM is next scheduled to report earnings on 2026-07-30.